Determinants of forearm mineral density and its correlation with fracture history in women.
In order to evaluate the role of single photon absorptiometry (SPA) in the prediction of osteoporotic fracture risk, 1935 women, referred for measurement of forearm mineral density (FMD) at the distal radial site, were studied by questionnaire in a cross-sectional design. There was no significant decline in FMD until the age of 47, after which there was a linear decline with age of about 1.2% per year. There was no relationship between age and FMD, or forearm mineral content (FMC), in premenopausal women. There was a fall in FMD with the number of years since menopause, after correcting for the effects of age, of approximately 0.5% per year. Body weight was positively correlated with FMC in postmenopausal women. The duration of exposure to hormone replacement therapy (HRT) was positively correlated with FMD, and the magnitude of this effect was reduced the longer the delay between the onset of the menopause and the commencement of HRT. There was no significant association of FMD with calcium intake, weight-bearing exercise, tobacco or alcohol consumption, or family history of osteoporosis. FMD was significantly lower in postmenopausal women who reported fractures after the age of 25, after correcting for age and years postmenopause. In conclusion, a low FMD is predictive of a past history of fractures and may therefore be capable of predicting future fracture risk.
Gilfillan
C P
CP
Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria, Australia.
Silberberg
S
S
Scrivenor
P
P
Griffiths
R C
RC
McCloud
P I
PI
Burger
H G
HG
D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000886:Anthropometry; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology; D015444:Exercise / Q000502:physiology; D005260:Female; D005598:Fractures, Spontaneous / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology* / Q000517:prevention & control; D011884:Radius / Q000187:drug effects / Q000503:physiopathology; D012307:Risk Factors
D004967:Estrogens